USPTO serial 79346673
NANOENTEK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 21, 2024
- Examiner
- BARRETT, LEAH N
- Law office
- TMEG LAW OFFICE 106
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NANOENTEK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sangwon Kim
Sangwon Kim Revolution IP, PLLC2000 Duke Street, Suite 300Alexandria, VA 22314UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Flow-based analyzers providing particle and cell size analysis for medical purposes; flow cytometers for medical diagnosis; electroporators for biomolecules or drugs for medical purposes; flow-based analyzers providing automated cell counting for medical purposes; medical apparatus for automatic diagnosis of tuberculosis; urinalysis apparatus and instruments, namely, fluorescence immunoassay analyzer for analyzing the protein in urine; immune affinity gas chromatography apparatus for medical use; capillary reagent tubes for medical use; medical diagnostic testing apparatus for testing for bacteria and viruses; medical diagnostic apparatus for testing cells for blood, serum, plasma, cell, molecule, and protein levels; medical instruments for measuring blood, serum, plasma, cell, molecule, and protein levels for cancer diagnosis; medical devices, namely, miniaturized sensors for gathering data in connection with gene analysis and diagnosis; immunochemical testing apparatus for medical diagnosis; apparatus for DNA and RNA testing for medical purposes; DNA extraction and purification apparatus for medical purposes; test equipment for medical use, namely, cell counter, live cell imager, fluorescence immunoassay analyzer and associated test tool; medical immunoassay chemical testing apparatus; immunofluorescence analysis apparatus for testing blood, serum, plasma, cell, molecule, and protein medical purposes; apparatus for use in medical analysis, namely, cell counter, live cell imager, fluorescence immunoassay analyzer and associated test tool; real-time gene amplification equipment for medical use; medical genetic analyzer; body fluid analysis apparatus for medical purposes; blood, serum, plasma, cell, molecule, and protein measuring devices for medical use; fluorescent nanoparticle immunoassay designed for in vitro quantitative measurement cartridges for medical purposes; medical absorption analysis apparatus, namely, cell counter, live cell imager, fluorescence immunoassay analyzer and associated test tool; apparatus for blood tests for medical use; apparatus for blood analysis for medical use; blood analysis apparatus for diagnosis; diagnostic apparatus and instruments for medical purposes, namely, cell counter, live cell imager, fluorescence immunoassay analyzer and associated test tool; urine analysis devices for medical diagnosis, namely, fluorescence immunoassay analyzer for analyzing the protein in urine; clinical-chemical auto analysis apparatus for medical diagnosis, namely, cell counter, live cell imager, fluorescence immunoassay analyzer and associated test tool; medical apparatus and instruments in the fields of clinical diagnosis, namely, cell counter, live cell imager fluorescence immunoassay analyzer and associated test tool; medical diagnostic apparatus, namely, cell counter, live cell imager, fluorescence immunoassay analyzer and associated test tool; apparatus for use in medical analysis, namely, cell counter, live cell imager, fluorescence immunoassay analyzer and associated test tool and arterial blood pressure measuring apparatus; in vitro diagnostic devices for medical purposes, namely, fluorescence immunoassay analyzer; cholesterol meters; medical instruments for measuring hematocrit; blood cell processing handler being sample pretreatment module; medical apparatus in the nature of hemocytometers; blood cell analysis apparatus; flow-based analyzers providing blood cell counting for medical purposes; blood glucose monitoring apparatus for medical purposes; filters for blood and blood components for medical purposes; blood testing apparatus; plasma separators in the nature of blood filters, centrifuge; apparatus for clinical diagnosis of cancer, hormone, thyroid, diabetes, infection, cardiac; capillary tubes for blood for medical use; capillary tubes for samples medical use; diagnostic, examination, and monitoring equipment, namely, cell counter, live cell imager fluorescence immunoassay analyzer and associated test tool; instruments for extracting human body fluids, namely, blood, urine, and saliva; apparatus for taking blood | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 30, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 9, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 9, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 21, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 21, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 21, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 5, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 5, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 14, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 14, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 14, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 29, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 29, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 10, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 10, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 29, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 28, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 28, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 21, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 21, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 21, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 17, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 24, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 27, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 9, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 8, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 1, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 9, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 5, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |